NCT03572205

Brief Summary

Interactions between genes and environment, are likely to be crucial in the development of the common diseases such as type 2 diabetes. Recently, the investigators have obtained data that genotypes of genes encoding for fatty acid desaturases 1 and 2 (FADS1 and FADS2) are the strongest genes in a genome-wide analysis regulating serum fatty acid profile.The aim of this study is to test if subjects with different genotypes of the FADS2 gene respond differently to a diet supplemented with linoleic acid or alpha-linolenic acid (substrates for FADS2). The study hypothesizes that subjects will be more sensitive to the dietary modifications according to their genotype leading to more robust differences in serum FA profile, tissue inflammation and serum lipids.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 13, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 28, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

August 13, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 19, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 19, 2018

Completed
Last Updated

April 18, 2019

Status Verified

April 1, 2019

Enrollment Period

4 months

First QC Date

June 13, 2018

Last Update Submit

April 17, 2019

Conditions

Keywords

Nutrigenetics

Outcome Measures

Primary Outcomes (1)

  • Change in fatty acid composition of serum lipid fractions

    Fatty acid composition of serum lipid fractions

    8 weeks

Secondary Outcomes (3)

  • Glucose and insulin metabolism response

    8 weeks

  • Inflammatory markers response

    8 weeks

  • Adipose tissue biopsies

    8 weeks

Study Arms (4)

CC genotype LA

EXPERIMENTAL

4-week study diet will be isocaloric following the habitual diet of the participants with a supplement of 30-50 ml (5-6 % of energy intake) of sunflower oil (source of LA: linoleic acid) daily, depending on body weight. The same diet will be instructed for both genotypes.

Dietary Supplement: LA

TT genotype LA

EXPERIMENTAL

4-week study diet will be isocaloric following the habitual diet of the participants with a supplement of 30-50 ml (5-6 % of energy intake) of sunflower oil (source of LA: linoleic acid) daily, depending on body weight. The same diet will be instructed for both genotypes.

Dietary Supplement: LA

CC genotype ALA

EXPERIMENTAL

4-week study diet will be isocaloric following the habitual diet of the participants with a supplement of 30-50 ml (5-6 % of energy intake) of camelina oil (source of alpha-linolenic acid: ALA) daily, depending on body weight. The same diet will be instructed for both genotypes.

Dietary Supplement: ALA

TT genotype ALA

EXPERIMENTAL

4-week study diet will be isocaloric following the habitual diet of the participants with a supplement of 30-50 ml (5-6 % of energy intake) of camelina oil (source of alpha-linolenic acid: ALA) daily, depending on body weight. The same diet will be instructed for both genotypes.

Dietary Supplement: ALA

Interventions

LADIETARY_SUPPLEMENT

The source of linoleic acid (LA) will be sunflower oil (62-63 % LA). The study diets will be isocaloric. The allowed weight change during the study is ± 2-3 %. The amount of supplementary oil will be calculated individually based on the calculated energy expenditure and adjusted, if necessary, during the study based on body weight measurements.

Also known as: sunflower oil
CC genotype LATT genotype LA
ALADIETARY_SUPPLEMENT

The source of alpha-linolenic acid (ALA) will be camelina sativa oil (30-35 % ALA). The study diets will be isocaloric. The allowed weight change during the study is ± 2-3 %. The amount of supplementary oil will be calculated individually based on the calculated energy expenditure and adjusted, if necessary, during the study based on body weight measurements.

Also known as: camelina oil
CC genotype ALATT genotype ALA

Eligibility Criteria

Age50 Years - 65 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsMen because the population source for recruitment Metabolic syndrome in men (METSIM) study is composed solely by men.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants of METSIM study cohort with CC/TT FADS1 rs174547 SNP genotype.
  • BMI 20-32 kg/m2.
  • Healthy .

You may not qualify if:

  • Diagnosis of type 2 diabetes.
  • Diagnosis of chronic diseases and conditions, that may hamper the ability to follow the dietary intervention protocol
  • Chronic liver, thyroid and kidney diseases
  • Alcohol abuse (\> 40 g/d)
  • BMI \>32 kg/m2.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Eastern Finland

Kuopio, 70211, Finland

Location

MeSH Terms

Interventions

Sunflower Oil

Intervention Hierarchy (Ancestors)

Plant OilsPlant PreparationsBiological ProductsComplex Mixtures

Study Officials

  • Jussi Pihlajamäki, MD

    University of Eastern Finland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 13, 2018

First Posted

June 28, 2018

Study Start

August 13, 2018

Primary Completion

December 19, 2018

Study Completion

December 19, 2018

Last Updated

April 18, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will not share

Locations